September 27, 2016 5:47 AM ET

Biotechnology

Company Overview of Shire plc

Key Executives for Shire plc

NameBoard RelationshipsTitleAge
Flemming Ornskov M.D., MBA, MPH11 RelationshipsChief Executive Officer, Managing Director, Director and Chairman of Executive Committee58
Jeffrey Poulton 11 RelationshipsChief Financial Officer, Director and Member of Executive Committee48
Reza Haque M.D., DO, Ph.D.No RelationshipsTherapeutic Area Head for Ophthalmology--
Arnaud Partiot M.D.No RelationshipsSenior Vice President of R&D--
Perry Sternberg No RelationshipsHead of US Commercial--
View More Key Executives

Shire plc Board Members*

NameBoard RelationshipsPrimary CompanyAge
Susan Saltzbart Kilsby 44 RelationshipsShire plc57
Flemming Ornskov M.D., MBA, MPH 11 RelationshipsShire plc58
Jeffrey Poulton 11 RelationshipsShire plc48
David Ginsburg M.D. 37 RelationshipsShire plc63
Anne E. Minto OBE 28 RelationshipsShire plc63
View All Board Members

Shire plc Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Dominic Blakemore22 Relationships5 Executives
Compensation Committee OBEAnne E. Minto28 Relationships6 Executives
Nominating Committee Susan Saltzbart Kilsby44 Relationships4 Executives
Corporate Governance Committee Susan Saltzbart Kilsby44 Relationships4 Executives
Executive Committee M.D., MBA, MPHFlemming Ornskov11 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$1.5M
1.5M
383.9K
Bonus$2.7M
2.7M
263.7K
Total Short Term Compensation$4.3M
4.3M
478.9K
Total Value of Options
33.7M
Compensation as of Fiscal Year
Shire plc CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

GlycoMimetics, Inc. Announces the Intention of Franklin H. Top to Resign as Directors Effective January 1, 2017
September 23, 2016 1:31 PM ET
Symic Bio Appoints Thomas N. Wight to Scientific Advisory Board
September 23, 2016 12:01 PM ET
Momenta Pharmaceuticals Inc. Appoints Corey N. Fishman to its Board of Directors
September 23, 2016 12:00 PM ET
uniQure N.V. Announces Management and Board Changes
September 22, 2016 8:18 PM ET
Ligand Pharmaceuticals Incorporated Announces Change of Principal Accounting Officer
September 22, 2016 8:06 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Shire plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.